in a double-blind trial lasting 6 months , 36 patients with classical or definity rheumatoid arthritis were divided into two groups , one receiving 3x300 mg proquazone/day and the other 2x250 mg naproxen plus one placebo capsule/day .
C0003873
rheumatoid arthritis
C0027396
naproxen